↑
Skip links

AI low-dose CT, proven performance in multinational clinical trials

2022-09-20

AI low-dose CT, proven performance in multinational clinical trials

The artificial intelligence (AI) low-dose CT technology developed in Korea has proven its performance in the first multinational clinical trial.

×

Join Us - WHX 2026

Feb 9, 2026 - Feb 12, 2026
Dubai Exhibition Centre

ClariPi will be at WHX 2026! If you are interested in our products, you could visit our booth or arrange a demo session online. Just message us to schedule a meeting! Thank you!

Booth Location: #TBA 

Click Here to find out more! Contact Us

Join Us - ECR 2026

Mar 4, 2026 - Mar 7, 2026
Vienna, Austria

ClariPi will be at ECR 2026! If you are interested in our products, you could visit our booth or arrange a demo session online. Just message us to schedule a meeting! Thank you!

Booth Location: #AI-17

Click Here to find out more! Contact Us